C. Wenzel
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 22
- Cancer Treatment and Pharmacology 12
- HER2/EGFR in Cancer Research 7
-
- Advanced Breast Cancer Therapies 7
- Co-authors
- C. Zielinski (6 shared papers)Michael Hejna (1 shared paper)Wolfgang J. Köstler (1 shared paper)Michael Gnant (10 shared papers)G. Steger (9 shared papers)Gottfried J. Locker (8 shared papers)R. Jakesz (6 shared papers)Ansgar Bernardi (1 shared paper)
In The Last Decade
C. Wenzel
37 papers receiving 637 citations
Peers
Comparison fields: 5 of 102
- Otorhinolaryngology 148
- Oncology 303
- Pulmonary and Respiratory Medicine 322
- Periodontics 31
- Cancer Research 86
Countries citing papers authored by C. Wenzel
This map shows the geographic impact of C. Wenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Wenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Wenzel more than expected).
Fields of papers citing papers by C. Wenzel
This network shows the impact of papers produced by C. Wenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Wenzel. The network helps show where C. Wenzel may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Wenzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 266 | |
| 2 | 2003 | 67 | |
| 3 | 2000 | 52 | |
| 4 | 2003 | 37 | |
| 5 | 2003 | 36 | |
| 6 | 2003 | 35 | |
| 7 | 2005 | 32 | |
| 8 | 2001 | 24 | |
| 9 | 2002 | 13 | |
| 10 | [Gallbladder cancer. Case-control study]. | 1995 | 13 |
| 11 | 2003 | 12 | |
| 12 | 2004 | 9 | |
| 13 | 2009 | 7 | |
| 14 | 2004 | 7 | |
| 15 | [Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)]. | 1999 | 6 |
| 16 | [CAA 19-9 and carcinoembryonic antigen in gallbladder cancer]. | 1996 | 6 |
| 17 | 2002 | 5 | |
| 18 | 2002 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2023 | 4 |
About C. Wenzel
C. Wenzel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 40 papers that have together received 673 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), HER2/EGFR in Cancer Research (7 papers), Breast Cancer Treatment Studies (7 papers), Advanced Breast Cancer Therapies (7 papers), Semantic Web and Ontologies (3 papers), Estrogen and related hormone effects (3 papers), Business Process Modeling and Analysis (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Otorhinolaryngology (148 citations), Oncology (303 citations), Pulmonary and Respiratory Medicine (322 citations), Periodontics (31 citations) and Cancer Research (86 citations). C. Wenzel has collaborated with scholars based in Austria, Germany and Chile. Frequent co-authors include C. Zielinski, Michael Hejna, Wolfgang J. Köstler, Michael Gnant, G. Steger, Gottfried J. Locker, R. Jakesz, Ansgar Bernardi, Michael Sintek and Heiko Maus. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer, Biomedicines and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.